Recently, we integrated the multi-layered evidence to establish a novel oncogenic attribute of overexpressed RSF1, which co-opts CEBP/β and hSNF2H to transactivate IL-1β, in turns promoting angiogenesis in myxofibrosarcomas 11. Here, RSF1 is linked to myxofibrosarcoma.